Publications

Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.

Brissett DI, Whistler JL, van Rijn RM

2011
Protein aggregates in Huntington's disease.

Arrasate M, Finkbeiner S

2011
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.

Morris M, Koyama A, Masliah E, Mucke L

2011
Protein aggregates in Huntington's disease.

Arrasate M, Finkbeiner S

2011
Chemical informatics and target identification in a zebrafish phenotypic screen.

Laggner C, Kokel D, Setola V, Tolia A, Lin H, Irwin JJ, Keiser MJ, Cheung CY, Minor DL, Roth BL, Peterson RT, Shoichet BK

2011
Chemical informatics and target identification in a zebrafish phenotypic screen.

Laggner C, Kokel D, Setola V, Tolia A, Lin H, Irwin JJ, Keiser MJ, Cheung CY, Minor DL, Roth BL, Peterson RT, Shoichet BK

2011
Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins.

Mattis J, Tye KM, Ferenczi EA, Ramakrishnan C, O'Shea DJ, Prakash R, Gunaydin LA, Hyun M, Fenno LE, Gradinaru V, Yizhar O, Deisseroth K

2011
Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins.

Mattis J, Tye KM, Ferenczi EA, Ramakrishnan C, O'Shea DJ, Prakash R, Gunaydin LA, Hyun M, Fenno LE, Gradinaru V, Yizhar O, Deisseroth K

2011
Searching for Potocki-Lupski syndrome phenotype: a patient with language impairment and no autism.

Gulhan Ercan-Sencicek A, Davis Wright NR, Frost SJ, Fulbright RK, Felsenfeld S, Hart L, Landi N, Einar Mencl W, Sanders SJ, Pugh KR, State MW, Grigorenko EL

2011
RIM-binding protein, a central part of the active zone, is essential for neurotransmitter release.

Liu KS, Siebert M, Mertel S, Knoche E, Wegener S, Wichmann C, Matkovic T, Muhammad K, Depner H, Mettke C, Bückers J, Hell SW, Müller M, Davis GW, Schmitz D, Sigrist SJ

2011

Pages